2014
DOI: 10.1038/srep05832
|View full text |Cite
|
Sign up to set email alerts
|

Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study

Abstract: High serum free fatty acid (FFA) levels are associated with metabolic syndrome (MS). This study aimed to assess the association of fasting serum FFAs with nonalcoholic fatty liver disease (NAFLD) in a Chinese population. A total of 840 subjects fulfilled the diagnostic criteria of NAFLD and 331 healthy control participants were enrolled in this cross-sectional study. Fasting serum FFA levels and other clinical and laboratory parameters were measured. NAFLD patients had significantly higher serum FFA levels tha… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

7
108
1
1

Year Published

2015
2015
2022
2022

Publication Types

Select...
10

Relationship

2
8

Authors

Journals

citations
Cited by 141 publications
(117 citation statements)
references
References 56 publications
7
108
1
1
Order By: Relevance
“…In the postprandial state, a reduction in the antilipolytic action of insulin, leading to elevated serum FFA and glycerol, takes place (85). In humans, venous drainage of visceral adipose tissue is via the portal vein, which provides FFA and glycerol as substrates for hepatic lipid and glucose metabolism (266,290,355), while the increased lipolysis in the retroperitoneal and epididymal fat depots constitutes the main source for these metabolites for hepatic metabolism in rodents (92, 311). The elevated concentrations of FFA reduce the degradation of apolipoprotein B and insulin, which may contribute to the development of the dyslipidemia, hyperinsulinemia, and insulin resistance observed in visceral obesity (178,262,328).…”
Section: Recruitment Of Proinflammatory Immune Cells In Obesity Perpementioning
confidence: 99%
“…In the postprandial state, a reduction in the antilipolytic action of insulin, leading to elevated serum FFA and glycerol, takes place (85). In humans, venous drainage of visceral adipose tissue is via the portal vein, which provides FFA and glycerol as substrates for hepatic lipid and glucose metabolism (266,290,355), while the increased lipolysis in the retroperitoneal and epididymal fat depots constitutes the main source for these metabolites for hepatic metabolism in rodents (92, 311). The elevated concentrations of FFA reduce the degradation of apolipoprotein B and insulin, which may contribute to the development of the dyslipidemia, hyperinsulinemia, and insulin resistance observed in visceral obesity (178,262,328).…”
Section: Recruitment Of Proinflammatory Immune Cells In Obesity Perpementioning
confidence: 99%
“…Excessive TG deposition in hepatocytes derives from an increased delivery of FFA into the liver, leading to the development of NAFLD [3]. In obesity-associated NAFLD, FFA delivery to the liver is increased, especially during the fed state, due to adipose tissue insulin resistance [4].…”
Section: Introductionmentioning
confidence: 99%
“…The prevalence of NAFLD and NASH increases from around 20% and 3%, respectively, in the general population to 75% and 25–70%, respectively, in morbid obesity56. The excessive TG deposition in hepatocytes derives from an increased delivery of free fatty acids (FFA) into the liver from several different sources: excess dietary fat, higher FFA release from adipocytes via lipolysis, as well as increased de novo hepatic lipogenesis, ultimately leading to the development of obesity-associated NAFLD7. In addition, growing evidence indicates that hepatic mitochondrial dysfunction as well as alterations in autophagy are also involved in the development of this disease8.…”
mentioning
confidence: 99%